Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease

Area of Science:

• Genetics and Genomics
• Biobanking and Data Science
• Population Health and Epidemiology

Background:

• Genome-wide association studies (GWASs) have identified genetic loci for numerous human diseases and traits.
• Existing biobanks predominantly comprise individuals of European ancestry, limiting generalizability.
• A need exists for more diverse and inclusive genetic datasets to advance precision medicine.

Purpose of the Study:

• To introduce the Global Biobank Meta-analysis Initiative (GBMI), a large-scale collaborative network.
• To meta-analyze genome-wide association studies (GWASs) across diverse biobanks and populations.
• To validate the integration of GWAS summary statistics from heterogeneous biobank data.

Main Methods:

• Established a collaborative network of 23 biobanks across 4 continents.
• Harmonized genotypes and phenotypes from over 2.2 million consented individuals.
• Performed meta-analysis of GWAS summary statistics for 14 exemplar diseases and endpoints.

Main Results:

• Successfully integrated GWAS data from diverse biobanks, demonstrating robustness despite heterogeneity.
• Enhanced statistical power for GWASs, particularly benefiting understudied diseases.
• Improved disease risk prediction models and identified potential disease genes and drug candidates.

Conclusions:

• The Global Biobank Meta-analysis Initiative (GBMI) effectively integrates diverse genetic and health records.
• This collaborative approach enhances the power and scope of genome-wide association studies (GWASs).
• GBMI provides valuable insights into human disease biology, gene function, and therapeutic targets.